Anti-parasitic Antibodies from Phage Display

Adv Exp Med Biol. 2017:1053:155-171. doi: 10.1007/978-3-319-72077-7_8.

Abstract

Parasite infections affect billions of people and their domesticated animals worldwide, and remain as a significant cause of morbidity and mortality, but such diseases are still neglected in endemic countries. Therapeutic interventions consisted mostly of drugs, which are highly toxic and may lead to resistance. The immunopathology of parasites is very complex due to their multistage life cycles and long lifetime involving several hosts, leading many times to chronic infections and sometimes to death, by compromising nutritional status, affecting cognitive processes, and inducing severe tissue reactions. Vaccination is a challenge, and immunotherapy is completely disregarded because of their complex interactions with hosts and vectors. This review will bring concepts of immunological aspects for some important parasitic infections, and present the most recent phage display-derived antibodies or peptidomimetics for parasite targets. This chapter will also discuss the future perspectives of such potential anti-infective immunobiologicals for parasitic diseases.

Keywords: Antibody; Helminthiasis; Immunopathology; Leishmaniasis; Malaria; Parasitic diseases; Phage display; Schistosomiasis; Toxoplasmosis.

Publication types

  • Review

MeSH terms

  • Animals
  • Antibodies / adverse effects
  • Antibodies / immunology
  • Antibodies / therapeutic use*
  • Antiparasitic Agents / adverse effects
  • Antiparasitic Agents / immunology
  • Antiparasitic Agents / therapeutic use*
  • Cell Surface Display Techniques*
  • Host-Parasite Interactions
  • Humans
  • Parasites / drug effects*
  • Parasites / immunology
  • Parasites / pathogenicity
  • Parasitic Diseases / drug therapy*
  • Parasitic Diseases / immunology
  • Parasitic Diseases / parasitology
  • Peptide Library*

Substances

  • Antibodies
  • Antiparasitic Agents
  • Peptide Library